These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 10797087

  • 1. In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method.
    López-Jodra O, Torres-Rodríguez JM, Méndez-Vásquez R, Ribas-Forcadell E, Morera-López Y, Baró-Tomás T, Alia-Aponte C.
    J Antimicrob Chemother; 2000 May; 45(5):645-9. PubMed ID: 10797087
    [Abstract] [Full Text] [Related]

  • 2. In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs.
    Abdel-Salam HA.
    Mycoses; 2005 Sep; 48(5):327-32. PubMed ID: 16115103
    [Abstract] [Full Text] [Related]

  • 3. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW, Johnson EM, Rogers TR.
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [Abstract] [Full Text] [Related]

  • 4. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.
    Espinel-Ingroff A, Pfaller M, Messer SA, Knapp CC, Killian S, Norris HA, Ghannoum MA.
    J Clin Microbiol; 1999 Mar; 37(3):591-5. PubMed ID: 9986817
    [Abstract] [Full Text] [Related]

  • 5. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
    Tay ST, Tanty Haryanty T, Ng KP, Rohani MY, Hamimah H.
    Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
    [Abstract] [Full Text] [Related]

  • 6. Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans.
    Davey KG, Szekely A, Johnson EM, Warnock DW.
    J Antimicrob Chemother; 1998 Oct; 42(4):439-44. PubMed ID: 9818741
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.
    Aller AI, Martín-Mazuelos E, Gutiérrez MJ, Bernal S, Chávez M, Recio FJ.
    J Antimicrob Chemother; 2000 Dec; 46(6):997-1000. PubMed ID: 11102421
    [Abstract] [Full Text] [Related]

  • 8. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
    To WK, Fothergill AW, Rinaldi MG.
    J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of MIC Test Strip and Sensititre YeastOne with the CLSI and EUCAST Broth Microdilution Reference Methods for In Vitro Antifungal Susceptibility Testing of Cryptococcus neoformans.
    Delma FZ, Al-Hatmi AMS, Buil JB, van der Lee H, Tehupeiory-Kooreman M, de Hoog GS, Meletiadis J, Verweij PE.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 32015025
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.
    Bernal S, Aller AI, Chávez M, Valverde A, Serrano C, Gutiérrez MJ, Quindós G, Martín Mazuelos E.
    Chemotherapy; 2002 Mar 24; 48(1):21-5. PubMed ID: 11901252
    [Abstract] [Full Text] [Related]

  • 12. Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans.
    Perkins A, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M.
    J Antimicrob Chemother; 2005 Dec 24; 56(6):1144-7. PubMed ID: 16282208
    [Abstract] [Full Text] [Related]

  • 13. Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
    Del Poeta M, Barchiesi F, Morbiducci V, Arzeni D, Marinucci G, Ancarani F, Scalise G.
    J Chemother; 1994 Jun 24; 6(3):173-6. PubMed ID: 7983499
    [Abstract] [Full Text] [Related]

  • 14. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998.
    Brandt ME, Pfaller MA, Hajjeh RA, Hamill RJ, Pappas PG, Reingold AL, Rimland D, Warnock DW, Cryptococcal Disease Active Surveillance Group.
    Antimicrob Agents Chemother; 2001 Nov 24; 45(11):3065-9. PubMed ID: 11600357
    [Abstract] [Full Text] [Related]

  • 15. Turbidimetric and visual criteria for in vitro susceptibility testing of Cryptococcus neoformans clinical isolates.
    Del Poeta M, Barchiesi F, Arzeni D, Marinucci G, Scalise G.
    Mycoses; 1994 Nov 24; 37(11-12):411-6. PubMed ID: 7659128
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.
    Pfaller MA, Barry AL.
    J Clin Microbiol; 1994 Aug 24; 32(8):1992-6. PubMed ID: 7989555
    [Abstract] [Full Text] [Related]

  • 17. Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil.
    Souza LK, Fernandes Ode F, Kobayashi CC, Passos XS, Costa CR, Lemos JA, Souza-Júnior AH, Silva Mdo R.
    Rev Inst Med Trop Sao Paulo; 2005 Aug 24; 47(5):253-6. PubMed ID: 16302107
    [Abstract] [Full Text] [Related]

  • 18. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
    Gutch RS, Nawange SR, Singh SM, Yadu R, Tiwari A, Gumasta R, Kavishwar A.
    Braz J Microbiol; 2015 Aug 24; 46(4):1125-33. PubMed ID: 26691471
    [Abstract] [Full Text] [Related]

  • 19. Antifungal susceptibility testing with YeastONE™ is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia.
    Yang JH, Huang PY, Cheng CW, Shie SS, Lin ZF, Yang LY, Lee CH, Wu TS.
    Med Mycol; 2021 Nov 03; 59(11):1114-1121. PubMed ID: 34374784
    [Abstract] [Full Text] [Related]

  • 20. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
    Arthington-Skaggs BA, Motley M, Warnock DW, Morrison CJ.
    J Clin Microbiol; 2000 Jun 03; 38(6):2254-60. PubMed ID: 10834985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.